Location History:
- South San Francisco, CA (US) (2024)
- San Mateo, CA (US) (2024)
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Teemu Tapani Junttila in Targeted Cancer Therapies
Introduction
Teemu Tapani Junttila, based in South San Francisco, California, is a notable inventor in the field of biopharmaceuticals. With a strong focus on cancer treatments, he holds two significant patents that contribute to advancements in targeted therapies. His work has potential implications for improving the efficacy of cancer treatments, making him a valuable asset in the medical research community.
Latest Patents
Teemu Tapani Junttila's latest patents include groundbreaking innovations. The first patent, titled “HER2-targeting antigen binding molecules comprising 4-1BBL,” relates to Her2 targeting 4-1BB agonists. This invention particularly focuses on 4-1BBL trimer-containing antigen binding molecules, which include at least one antigen binding domain capable of specific binding to Her2. These molecules are designed for the treatment of cancer and can be used in combination with T-cell activating anti-CD3 bispecific antibodies.
The second patent, “Agonistic CD28 antigen binding molecules targeting Her2,” presents Her2-targeted bispecific agonistic CD28 antigen binding molecules characterized by monovalent binding to CD28. It details methods for their production, pharmaceutical compositions that contain these antibodies, and various methods of using them in therapeutic applications.
Career Highlights
Teemu's career at Hoffmann-La Roche Inc. has enabled him to translate his innovative ideas into practical solutions for complex medical challenges. His expertise in cancer immunotherapy has been instrumental in the development of cutting-edge treatments that target specific cancer biomarkers, ultimately aiming to improve patient outcomes.
Collaborations
Throughout his career, Teemu has collaborated with esteemed colleagues such as Christian Klein and Stephan Gasser. These collaborations have fostered an environment of innovation and discovery, allowing the team to combine their knowledge and skills to push the boundaries of cancer therapies.
Conclusion
Teemu Tapani Junttila's work and patents are reshaping the future of cancer treatment through targeted therapies. His contributions at Hoffmann-La Roche Inc. highlight the importance of innovation and collaboration in the medical field. By focusing on the advancement of Her2-targeted therapies, Teemu continues to pave the way for more effective cancer treatments, benefiting both the scientific community and patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.